Lymphoma
Showing NaN - NaN of 168
Leukemia, Lymphoma, Multiple Myeloma Trial in Boston (Umbilical Cord Blood After Myeloablative Conditioning, Umbilical Cord
Terminated
- Leukemia
- +3 more
- Umbilical Cord Blood After Myeloablative Conditioning
- Umbilical Cord Blood After Reduced-Intensity Conditioning
-
Boston, MassachusettsTufts Medical Center
May 1, 2017
Leukemia, Lymphoma, Myelodysplastic Syndrome Trial in Boston (Bortezomib, Tacrolimus, Methotrexate)
Completed
- Leukemia
- +2 more
- Bortezomib
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
May 23, 2017
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Boston (drug, procedure, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +6 more
- busulfan
- +12 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 20, 2017
Chronic Lymphocytic Leukemia, Lymphoma, Multiple Myeloma Trial in Boston (Plerixafor)
Terminated
- Chronic Lymphocytic Leukemia
- +2 more
-
Boston, MassachusettsTufts Medical Center
May 5, 2017
Multiple Myeloma, Lymphoma Trial in Boston (Lenalidomide)
Terminated
- Multiple Myeloma
- Lymphoma
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Apr 14, 2017
GVHD, Leukemia, Lymphoma Trial in Boston, Minneapolis (drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +4 more
- cyclophosphamide
- +6 more
-
Boston, Massachusetts
- +1 more
Mar 30, 2017
Lymphoma Trial in Boston (Allogeneic stem cell transplantation, Fludarabine, Thiotepa)
Withdrawn
- Lymphoma
- Allogeneic stem cell transplantation
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 21, 2017
Lymphoma Trial in United States (biological, drug, radiation)
Completed
- Lymphoma
- rituximab
- +5 more
-
Mobile, Alabama
- +91 more
Jan 12, 2017
Cachexia, Lymphoma, Lymphoproliferative Disorder Trial in Canada, United States (Juven, Non-Juven Supplement)
Completed
- Cachexia
- +3 more
- Juven
- Non-Juven Supplement
-
Birmingham, Alabama
- +249 more
Dec 6, 2016
Lymphoma, Infection, Leukemia Trial in United States (Fluconazole, Voriconazole)
Completed
- Lymphoma
- +2 more
-
Birmingham, Alabama
- +32 more
Aug 1, 2016
GVHD, Lymphoma Trial in United States (carmustine, melphalan, etoposide)
Completed
- Graft Versus Host Disease
- Lymphoma
- carmustine
- +7 more
-
Birmingham, Alabama
- +47 more
Jul 15, 2016
Lymphoma Trial in Puerto Rico, United States (filgrastim, rituximab, cyclophosphamide)
Completed
- Lymphoma
- filgrastim
- +6 more
-
Anniston, Alabama
- +80 more
Jul 15, 2016
Lymphoma Trial in Puerto Rico, United States (biological, drug, procedure)
Completed
- Lymphoma
- filgrastim
- +11 more
-
Anniston, Alabama
- +80 more
Jul 15, 2016
Lymphoma Trial in Puerto Rico, United States (doxorubicin HCl, topotecan HCl)
Completed
- Lymphoma
- doxorubicin hydrochloride
- topotecan hydrochloride
-
Anniston, Alabama
- +75 more
Jul 12, 2016
Lymphoma Trial in Puerto Rico, United States (gemcitabine HCl, pegylated liposomal doxorubicin HCl, vinorelbine tartrate)
Completed
- Lymphoma
- gemcitabine hydrochloride
- +2 more
-
Anniston, Alabama
- +75 more
Jul 12, 2016
Lymphoma Trial in United States (filgrastim, cyclophosphamide, doxorubicin HCl)
Completed
- Lymphoma
- filgrastim
- +5 more
-
Birmingham, Alabama
- +46 more
Jul 12, 2016
Patients With Aggressive Non-Hodgkin's Lymphoma
Completed
- Lymphoma
- comparative genomic hybridization
- +3 more
-
Anniston, Alabama
- +68 more
Jul 1, 2016
Lymphoma Trial in United States (rituximab, yttrium Y 90 ibritumomab tiuxetan)
Completed
- Lymphoma
- rituximab
- yttrium Y 90 ibritumomab tiuxetan
-
Little Rock, Arkansas
- +93 more
Jul 1, 2016
Lymphoma Trial in United States (doxorubicin HCl, gemcitabine HCl, vinblastine)
Completed
- Lymphoma
- doxorubicin hydrochloride
- +4 more
-
San Francisco, California
- +46 more
Jun 30, 2016
Lymphoma, Leukemia, Multiple Myeloma Trial in Boston (sequential cord blood transplantation)
Completed
- Lymphoma
- +3 more
- sequential cord blood transplantation
-
Boston, Massachusetts
- +1 more
May 9, 2016